Study of AMG 650 in Adult Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
MTD, Safety and Efficacy of NYH817G and NYH100P in Monotherapy and Combination in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
IPH5201 as Monotherapy or in Combination With Durvalumab +/- Oleclumab in Subjects With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Safety and Clinical Activity of AB122 in Biomarker Selected Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FPT155 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1